Search Results 1511-1520 of 19460 for Hemoglobin

1. A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva - Mayo Clinic

   Uncontrolled diabetes defined as hemoglobin A1C (HbA1c) >9% at screening (1 retest allowed). Cardiovascular conditions such as New York Heart Association ...

2. Publications - Leslie J. Padrnos, M.D. - Mayo Clinic

   ... hemoglobin Evans with secondary methemoglobinemia. J Clin Apher. 2023 Dec; 38 (6):755-759 Epub 2023 Sept 04. View PubMed; Riaz IB, Fuentes H, Deng Y, Naqvi ...

3. Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants - Mayo Clinic

   Positive Hemoglobin-Solubility (e.g., SickleDex™ or equivalent) test. Tests confirmed positive for HIV-1/2, human T-cell lymphotropic virus (HTLV)-I/II ...

4. Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer - Mayo Clinic

   Hemoglobin (Hgb) ≥ 90 g/L,; Platelets (plt) ≥ 100 x 109/L,; Potassium within normal range, or correctable with supplements,; Aspartate Aminotransferase (AST) ...

5. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

   Hemoglobin < 9.0 g/dL. Insufficient hepatic and renal function: Total bilirubin > 1.5x ULN;; AST/SGOT and ALT/SGPT > 2.5x ULN (AST and ALT > 5x ULN in the ...

6. Abiraterone/Prednisone, Olaparib, Or Abiraterone/Prednisone + Olaparib In Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects - Mayo Clinic

   ANC > or = 1500/µl Hemoglobin ≥ 10.0 g/dL WBC > 3x10^9/L Platelet count 100,000/µl Creatinine ≥51 mL/min estimated using the Cockcroft-Gault equation ...

7. Study to Evaluate the Efficacy and Safety of Lutathera in Patients with Grade 2 and Grade 3 Advanced GEP-NET - Mayo Clinic

   Uncontrolled diabetes mellitus as defined by hemoglobin A1c value > 7.5%. Hyperkaleamia > 6.0 mmol/L (CTCAE Grade 3) which is not corrected prior to study ...

8. A Study of PY314 in Subjects With Advanced Solid Tumors - Mayo Clinic

   ... Hemoglobin ≥ 8.0 g/dL; ANC ≥ 1.5 x 10^9/L (without granulocytic growth factors within the previous 7 days of obtaining the screening hematologic ...

9. Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer - Mayo Clinic

   - Hemoglobin >= 9.0g/dL - Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 ...

10. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

    Adequate hematology without transfusional support (hemoglobin > 9 g/dL, ANC > 1,500 per mm3, platelets > 100,000 per mm3). Blood transfusion or growth ...